Orthopediatrics director gets 11,436-share stock award

Throdahl Mark C reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Throdahl Mark C reported acquisition or exercise transactions in this Form 4 filing.

ORTHOPEDIATRICS CORP director Mark C. Throdahl reported a stock award and updated share holdings. He received a grant of 11,436 shares of common stock at no cost, bringing his direct ownership to 179,317 shares, which includes 38,660 restricted stock awards.

He also reported 22,497 shares held indirectly through a trust. These entries reflect compensation-related equity awards and the current size of his direct and indirect positions, rather than open‑market buying or selling.

Insights

Equity Compensation Analyst

Routine director stock award increases reported equity stake.

The filing shows director Mark C. Throdahl receiving a grant of 11,436 shares of ORTHOPEDIATRICS CORP common stock at $0.00 per share. This appears to be standard equity compensation rather than an open-market purchase.

Following the grant, his direct holdings rise to 179,317 shares, including 38,660 restricted stock awards, while 22,497 shares are held indirectly by a trust. With no sales and no derivative exercises, the activity looks routine and compensation-driven, with limited informational value for near-term trading sentiment.

Insider Trade Summary

Grant/Award: 11,436 shares

Grant/Award 2 txns

Insider Throdahl Mark C

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	11,436	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 179,317 shares (Direct); Common Stock — 22,497 shares (Indirect, By Trust)

Footnotes (1)

1. F1. Includes restricted stock awards totaling 38,660 shares.

Key Figures

Stock grant: 11,436 shares Direct holdings after grant: 179,317 shares Indirect holdings by trust: 22,497 shares +2 more

5 metrics

Stock grant 11,436 shares Common stock award at $0.00 per share on 2026-06-09

Direct holdings after grant 179,317 shares Common stock directly owned following acquisition

Indirect holdings by trust 22,497 shares Common stock held indirectly through a trust

Restricted stock included 38,660 shares Restricted stock awards included within reported holdings

Grant price $0.00 per share Reported price for the 11,436-share award

Key Terms

restricted stock awards, indirect ownership, grant, award, or other acquisition, Form 4

4 terms

restricted stock awards financial

"Includes restricted stock awards totaling 38,660 shares."

Restricted stock awards are company shares given to employees or executives that cannot be sold or transferred until certain conditions — like staying with the company for a set time or meeting performance targets — are met, like a gift that is locked in a safe until rules are satisfied. Investors care because these awards tie management’s pay to company performance, can increase the number of shares outstanding when they become tradable (dilution), and may signal expected future selling pressure or commitment to long-term growth.

indirect ownership financial

"reported 22,497 shares held indirectly through a trust."

grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Mark C. Throdahl report in his latest Form 4 for ORTHOPEDIATRICS CORP (KIDS)?

Mark C. Throdahl reported receiving a stock grant of 11,436 ORTHOPEDIATRICS CORP common shares at no cost. The filing also updates his direct and indirect shareholdings, including restricted stock awards and shares held through a trust.

How many ORTHOPEDIATRICS CORP (KIDS) shares did Mark C. Throdahl acquire in this filing?

He acquired 11,436 shares of ORTHOPEDIATRICS CORP common stock via a compensation-related grant. The award was reported at a price of $0.00 per share, indicating it is an equity incentive, not an open-market purchase of shares.

What are Mark C. Throdahl’s direct ORTHOPEDIATRICS CORP (KIDS) holdings after the reported grant?

After the grant, his direct ownership totals 179,317 ORTHOPEDIATRICS CORP common shares. This amount includes 38,660 shares in the form of restricted stock awards, reflecting equity compensation that typically vests over time based on service or performance conditions.

Does the ORTHOPEDIATRICS CORP (KIDS) Form 4 show any stock sales by Mark C. Throdahl?

The Form 4 does not show any stock sales by Mark C. Throdahl. It reports a stock grant coded as an acquisition and provides updated direct and indirect holdings, including shares held in trust and restricted stock awards.

How many ORTHOPEDIATRICS CORP (KIDS) shares does Mark C. Throdahl hold indirectly?

He reports 22,497 ORTHOPEDIATRICS CORP common shares held indirectly through a trust. This indirect position is separate from his 179,317 directly held shares and reflects additional economic exposure managed via a trust structure.

Are restricted stock awards included in Mark C. Throdahl’s reported ORTHOPEDIATRICS CORP (KIDS) holdings?

Yes. A footnote explains that his reported holdings include restricted stock awards totaling 38,660 shares. These restricted shares form part of his direct 179,317-share position and represent equity compensation subject to vesting conditions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/10/2026 - 09:49 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Throdahl Mark C

(Last) (First) (Middle)

C/O ORTHOPEDIATRICS CORP.

2850 FRONTIER DRIVE

(Street)

WARSAW INDIANA 46582

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ORTHOPEDIATRICS CORP [ KIDS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/09/2026		A		11,436	A	$0	179,317(1)	D
Common Stock								22,497	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes restricted stock awards totaling 38,660 shares.

Remarks:

	/s/ Daniel J. Gerritzen, Attorney-in-Fact	06/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)